MAP3K8/Tpl2/COT Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 4 publications

Supplier:  Novus Biologicals NBP16217850UG

Catalog No. NBP16217850

Description

MAP3K8/Tpl2/COT Polyclonal specifically detects MAP3K8/Tpl2/COT in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Paraffin.

Specifications

• Antigen: MAP3K8/Tpl2/COT
• Classification: Polyclonal
• Dilution: Western Blot > 1:500, ELISA < 1:10000, Immunohistochemistry 1:50-1:150, Immunoprecipitation 1:200, Immunohistochemistry-Paraffin 1:50-1:150
• Gene Alias: Cancer Osaka thyroid oncogene, c-COT, cot (cancer Osaka thyroid) oncogene, COTMEKK8, EC 2.7.11.25, ESTF, ESTFLJ10486, Ewing sarcoma transformant, mitogen-activated protein kinase kinase kinase 8, Proto-oncogene c-Cot, proto-oncogene serine/threoine protein kinase, Serine/threonine-protein kinase cot, Tpl-2, TPL2, Tumor progression locus 2, tumor progression locus-2
• Host Species: Rabbit
• Quantity: 50 μg
• Gene ID (Entrez): 1326
• Target Species: Human, Mouse, Rat
• Isotype: IgG

• Applications: Western Blot, ELISA, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Paraffin)
• Conjugate: Unconjugated
• Formulation: Tris/Glycine buffer, pH 7.4; cryoprotective agents; HEPES; stabilizing protein (BSA 0.5%), and glycerol (30%). with 0.02% sodium azide
• Gene Symbols: MAP3K8
• Immunogen: Synthetic peptides corresponding to unique epitope on MAP3K8. The peptide sequence was selected from C-terminal-region, amimo acids 365-467. This peptide was covalently modified post-synthetically to achieve desired antigenicity.
• Primary or Secondary: Primary
• Test Specificity: This antibody detects a single band of approximately 57kDa in PC-MAP3K8 samples
• Content And Storage: Store at -20°C. Avoid freeze-thaw cycles.